Ovarian cancer ranks among the most frightening female reproductive system malignancies worldwide, striking thousands of women every year and delivering a devastating blow to patients “Recurrent Platinum-Resistant Ovarian Cancer: The RC48 + Anlotinib Combination Trial”
Category: ovarian cancer
ovarian cancer